Titan Pharmaceuticals Shares Jump 23% in After-Hours Trading Following Stockholder Endorsement of Three-Way Merger

Stock Surge After Merger Approval: Titan Pharmaceuticals, Inc. saw its stock price rise 23% in after-hours trading to $6.15 following the approval of a major business combination by stockholders.

Merger Details: Stockholders overwhelmingly approved a three-way merger with Black Titan Corporation and TalenTec Sdn. Bhd., with 730,383 votes in favor and only 1,860 against.

Market Impact: The company's stock has experienced significant volatility over the past year, with a market capitalization of $6.70 million and an average daily trading volume of 39,920 shares.

Remaining Conditions: The merger is still subject to additional closing conditions, including Nasdaq listing approval for Black Titan ordinary shares, as outlined in the original agreement dated August 19, 2024.